Icon
+91 94997 68112
Login Register
New Suitability Petitions - October 2024

Please find attached the report on list of drugs with Suitability Petitions activities for the month of October 2024 (filed / accepted / rejected / approved). The current month report covers the below products:

  1. DANTROLENE SODIUM
  2. CETRORELIX ACETATE
  3. CYPROHEPTADINE HYDROCHLORIDE
  4. PIROXICAM
  5. PIROXICAM
  6. NELARABINE
  7. TOPIRAMATE
  8. AMANTADINE HYDROCHLORIDE
  9. NEOSTIGMINE METHYLSULFAT
  10. NEOSTIGMINE METHYLSULFAT
  11. LEVETIRACETAM
  12. DICLOFENAC POTASSIUM
  13. LACOSAMIDE
  14. BUSPIRONE HYDROCHLORIDE
  15. BUSPIRONE HYDROCHLORIDE
  16. ESCITALOPRAM OXALATE
  17. ESCITALOPRAM OXALATE
  18. OLAPARIB
  19. BUPRENORPHINE HYDROCHLORIDE
  20. APIXABAN
  21. CARBINOXAMINE MALEATE
  22. CYCLOBENZAPRINE HYDROCHLORIDE
  23. CYCLOBENZAPRINE HYDROCHLORIDE
  24. METHIMAZOLE
  25. BENAZEPRIL HYDROCHLORIDE;  HYDROCHLOROTHIAZIDE
  26. BENAZEPRIL HYDROCHLORIDE
  27. HYDROCHLOROTHIAZIDE
  28. PIROXICAM
  29. HYDROCHLOROTHIAZIDE
  30. NILOTINIB HYDROCHLORIDE

Your web browser doesn't have a PDF plugin. Instead you can click here to download the PDF file.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.